SCHEMBL1481133

SCHEMBL1481133

O=C(O)c1cccn2cc(-c3ccccc3)nc12

nearest known ligand 0.94

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.94
ALDH1A3 P47895 4/20 0.64
ALDH1A2 O94788 3/20 0.64
ALDH1A1 P00352 7/20 0.62
KDM4E B2RXH2 6/20 0.62
NPC1 O15118 4/20 0.62
RAB9A P51151 4/20 0.62
HSD17B10 Q99714 4/20 0.62
HPGD P15428 2/20 0.62
TP53 P04637 2/20 0.62
NPSR1 Q6W5P4 2/20 0.62
TSHR P16473 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
HTR2A P28223 1/20 0.53
TMIGD3 P0DMS9 5/20 0.52
ADORA3 P0DMS8 3/20 0.52
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10211959 0.97 DHODH (1.00) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL5071964 0.89 DHODH (0.76) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL18038275 0.88 DHODH (0.79) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL5333968 0.88 DHODH (0.79) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL5073318 0.87 DHODH (0.82) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL14836765 0.86 DHODH (0.71) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL9091153 0.84 DHODH (0.73) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL1419869 0.84 DHODH (0.73) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL8867127 0.84 DHODH (0.73) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E
SCHEMBL12753158 0.84 DHODH (0.69) DHODHALDH1A3ALDH1A2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210128552-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2021-05-06 US disclosed
US-20190142826-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2019-05-16 US disclosed
US-10058549-B2 Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto ARENA PHARMACEUTICALS, INC. (US) 2018-08-28 US disclosed
US-20170151236-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. 2017-06-01 US disclosed
EP-2190844-B3 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2013-07-17 EP disclosed
EP-2190844-B1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2013-04-10 EP disclosed
US-8404707-B2 Imidazo [1, 2-a] pyrrolo [3, 2-c] pyridine compounds useful as pestivirus inhibitors UNIVERSITE D'AUVERGNE CLERMONT 1 (FR) 2013-03-26 US disclosed
US-20110077248-A1 IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRTRIS PHARMACEUTICALS, INC. 2011-03-31 US disclosed
US-20100093781-A1 IMIDAZO [1, 2-A] PYRROLO [3, 2-C] PYRIDINE COMPOUNDS USEFUL AS PESTIVIRUS INHIBITORS UNIVERSITE D'AUVERGNE CLERMONT 1 (FR) 2010-04-15 US disclosed
EP-2125807-A2 IMIDAZO[1,2-A]PYRROLO[3,2-C]PYRIDINE COMPOUNDS USEFUL AS PESTIVIRUS INHIBITORS Katholieke Universiteit Leuven (BE) 2009-12-02 EP disclosed
WO-2008070937-A2 IMIDAZO [1, 2-A] PYRROLO [3, 2-C] PYRIDINE COMPOUNDS USEFUL AS PESTIVIRUS INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2008-06-19 WO disclosed
EP-1257551-B1 HETEROCYCLIC COMPOUNDS AND THEIR USE AS PARP INHIBITORS ABBOTT GMBH & CO KG (DE) 2007-09-05 EP disclosed
US-7041675-B2 Heterocyclic compounds and their use as PARP inhibitors ABBOTT GMBH & CO. KG (DE) 2006-05-09 US disclosed
US-20030134843-A1 Heterocyclic compounds and their use as parp inhibitors ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2003-07-17 US disclosed
US-5498774-A FUNGICIDES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-03-12 US disclosed
EP-0404190-B1 Condensed heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-10-25 EP disclosed
EP-0404190-A1 Condensed heterocyclic compounds, their production and use Takeda Chemical Industries, Ltd. (JP) 1990-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170151236-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO HTR2A, HTR1A, HTR2B DHODH 3446/4885ALDH1A3 3444/4885ALDH1A2 1534/4885
US-10058549-B2 Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto HTR1A, HTR2A, HTR5A DHODH 3148/4885ALDH1A3 2465/4885ALDH1A2 1070/4885
US-20110077248-A1 IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS SIRT3, SIRT1, SIRT2 DHODH 1141/4885ALDH1A3 2233/4885ALDH1A2 1871/4885
US-20030134843-A1 Heterocyclic compounds and their use as parp inhibitors PARP1, PARP2, PARP11 DHODH 1990/4885ALDH1A3 2928/4885ALDH1A2 2661/4885
US-20210128552-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO HTR1A, HTR2A, HTR2B DHODH 3514/4885ALDH1A3 3342/4885ALDH1A2 1544/4885
US-20190142826-A1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO HTR1A, HTR2A, HTR5A DHODH 3223/4885ALDH1A3 2484/4885ALDH1A2 1073/4885
US-20100093781-A1 IMIDAZO [1, 2-A] PYRROLO [3, 2-C] PYRIDINE COMPOUNDS USEFUL AS PESTIVIRUS INHIBITORS PPM1D, CDKN1A, PPM1A DHODH 497/4885ALDH1A3 3587/4885ALDH1A2 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.